Compare IRWD & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | LTBR |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 505.3M |
| IPO Year | 2010 | N/A |
| Metric | IRWD | LTBR |
|---|---|---|
| Price | $5.45 | $18.23 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.74 | N/A |
| AVG Volume (30 Days) | ★ 7.4M | 1.0M |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $338,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.22 | N/A |
| P/E Ratio | $29.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.53 | $5.63 |
| 52 Week High | $5.78 | $31.34 |
| Indicator | IRWD | LTBR |
|---|---|---|
| Relative Strength Index (RSI) | 77.47 | 62.07 |
| Support Level | $4.17 | $16.51 |
| Resistance Level | $4.80 | $18.91 |
| Average True Range (ATR) | 0.48 | 1.27 |
| MACD | 0.10 | 0.38 |
| Stochastic Oscillator | 81.68 | 89.01 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.